Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: A double‐blind trial

Abstract

Tacrolimus, at dosages of both 2 mg/day and 3 mg/day, is efficacious and safe as monotherapy for patients with active RA, but treatment with the 3-mg dose of tacrolimus resulted in generally better ACR response rates.